Premium
Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis
Author(s) -
Capkun Gorana,
Callan Aoife,
Tian Haijun,
Wei Zhongyuan,
Zhao Changgeng,
Agashivala Neetu,
Barghout Victoria
Publication year - 2017
Publication title -
muscle and nerve
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 145
eISSN - 1097-4598
pISSN - 0148-639X
DOI - 10.1002/mus.25686
Subject(s) - medicine , dysphagia , health care , myositis , retrospective cohort study , emergency department , muscle weakness , weakness , population , myalgia , physical therapy , emergency medicine , environmental health , surgery , psychiatry , economics , economic growth
We analyzed the burden of illness of sporadic inclusion body myositis (sIBM) patients and the costs to the healthcare system. Methods A retrospective cohort analysis of 333 sIBM patients aged ≥ 50 years was performed using United States (U.S.) claims data. sIBM patients were matched in a 1:5 ratio to randomly selected individuals with ≥1 healthcare encounter within the year of index date. Results sIBM patients presented with higher rates of disease‐ and muscle‐related conditions, such as myalgia, myositis, muscle weakness, dysphagia, pneumonia, and falls. Use of healthcare resources, including physical therapy, office visits, emergency room (ER) visits, and hospitalizations, was greater in sIBM patients. This was also reflected in significantly higher overall healthcare costs in the sIBM population driven mainly by more all‐cause office visits, all‐cause ER visits and hospitalizations. Conclusions sIBM imposes a substantial burden on U.S. patients in terms of additional healthcare usage and associated costs. Muscle Nerve 56 : 861–867, 2017